ID: 4347469 SOFTWARE SUPPORTED REMOTE THERAPEUTIC MONITORING FOR ATRIAL FIBRILLATION PATIENTS UNDERGOING ANTIARRHYTHMIC DRUG TREATMENT
AF affects over 10 million people in the United States and is commonly managed via antiarrhythmic drug (AAD) therapy for symptom and rhythm control. While AADs are known to improve cardiac outcomes in AF patients, these drugs often require three-day inpatient and routine hospitalizations for cardiac telemetry monitoring due to rare risk (<0.6%) of QT prolongation. The goal of this case series is to present a novel software platform that supports AAD therapy and remote ECG monitoring of varying duration.
Authors
- Margaret R. Ferrari (ORCID: https://orcid.org/0000-0003-0062-4334)
- Veena Ramanathan
- Douglas Corsi (ORCID: https://orcid.org/0000-0001-5133-0235)
- J Vidal (ORCID: https://orcid.org/0000-0002-3688-8908)
- Sara Fernández (ORCID: https://orcid.org/0000-0002-5207-8817)
- Bishow Paudel (ORCID: https://orcid.org/0000-0003-3381-3529)
- Hernán G. Morales (ORCID: https://orcid.org/0000-0002-2731-2739)
- Walker McHugh (ORCID: https://orcid.org/0000-0003-3194-8833)
- Kunj Patel (ORCID: https://orcid.org/0000-0003-4118-7556)
- Rachita Navara (ORCID: https://orcid.org/0000-0002-6183-4258)
- S. S. Sandhu
- M. Bharath (ORCID: https://orcid.org/0009-0000-1362-1568)
- Abhivadya Soi
- Nitish Naidu Boya
- Jean-Louis Savi de Tove
- Idris Ejaz Anwer
- Meghana Voddiraju
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.hroo.2025.07.064
- Primary Topic
- ECG Monitoring and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00